![Jeffrey Ives](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 28 416 $ in data 30/09/2026
Jeffrey L.
Ives is currently Independent Director at Acumen Pharmaceuticals, Inc. since 2014, Director at Astrocyte Pharmaceuticals, Inc. since 2014, and Principal at Neuropharma Advisors LLC since 2013.
Former positions include Chief Executive Officer & Director at Satori Pharmaceuticals, Inc. from 2009 to 2013, Director & Vice President-Business Development at Celgene Corp., Independent Director at CARA Therapeutics, Inc., Director at Pinteon Therapeutics, Inc., Director at Orthogonal Neuroscience (US), Inc., Senior Vice President at Pfizer Inc. from 2001 to 2007, Executive-in-Residence at PureTech Health LLC, Senior Vice President-Research Portfolio at Pfizer (St. Louis) from 2001 to 2007, and Venture Partner at New Leaf Venture Partners LLC from 2017 to 2021.
Education includes undergraduate studies at Colgate University and graduate and doctorate degrees from Yale University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 03/06/2026 | 12.800 ( 0,02% ) | 28 416 $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ACUMEN PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/05/2014 |
Neuropharma Advisors LLC | Corporate Officer/Principal | 01/09/2013 |
Astrocyte Pharmaceuticals, Inc.
 Astrocyte Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug development company | Direttore/Membro del Consiglio | 01/12/2014 |
| Società | Posizione | Fine |
|---|---|---|
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements. | Investitore di Private Equity | 01/03/2021 |
Satori Pharmaceuticals, Inc.
 Satori Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for alzheimer's disease | Amministratore Delegato | 01/01/2013 |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Corporate Officer/Principal | 01/01/2007 |
| PFIZER INC. | Corporate Officer/Principal | 01/01/2007 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 13 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Acumen Pharmaceuticals, Inc.
 Acumen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops medicines and diagnostics for Alzheimer's disease | Health Technology |
Satori Pharmaceuticals, Inc.
Satori Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for alzheimer's disease | Health Technology |
CARA Therapeutics, Inc.
 CARA Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes new chemical entities designed to fundamentally change the way acute pain, chronic pain and pruritus are managed | Health Technology |
Pinteon Therapeutics, Inc.
 Pinteon Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Colgate University
 Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance PureTech Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors. It provides financing for seed, early and later stage capital requirements. | Finance |
New Leaf Venture Partners LLC
New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements. | Finance |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Health Technology |
Neuropharma Advisors LLC | |
Astrocyte Pharmaceuticals, Inc.
Astrocyte Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug development company | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
